ciprofloxacin has been researched along with eye in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.03) | 18.7374 |
| 1990's | 8 (24.24) | 18.2507 |
| 2000's | 12 (36.36) | 29.6817 |
| 2010's | 9 (27.27) | 24.3611 |
| 2020's | 3 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Fouraker, BD; Jensen, HG; Stevens, SX | 1 |
| Adenis, JP; Denis, F; Mounier, M | 1 |
| Drusano, GL; Liu, W; Madu, A; Madu, C; Mayers, M; Miller, MH; Perkins, R | 1 |
| Holmes, EW; Jay, WM; Marchese, AL; Slana, VS | 1 |
| Ashton, P; Ax, D; Bierly, JR; Conklin, JD; Hainsworth, DP | 1 |
| Akkan, AG; Gök, A; Mutlu, I; Ozüner, Z; Ozyazgan, S; Pekel, H; Senses, V; Yigit, U | 1 |
| Dasari, S; Gopinathan, U; Nadkarni, MS; Rao, GN; Reddy, MK | 1 |
| Chaudhry, NA; Flynn, HW; Mello, MO; Miller, D; Murray, TG; Tabandeh, H | 1 |
| Agarwal, HC; Biswas, NR; Gupta, SK; Gupta, YK; Velpandian, T | 1 |
| Gatus, B; Goldberg, I; Graham, GG; Lam, CM; McLachlan, AJ; Morlet, N; Naidoo, D; Salonikas, C | 1 |
| Ali, A; Charoo, NA; Kohli, K | 1 |
| Chen, L; Jin, XY; Li, R; Luo, SY; Sun, XG; Wang, ZQ | 1 |
| Bhadra, D; Bhadra, S; Gupta, G; Jain, N; Umamaheshwari, RB | 1 |
| Mundada, AS; Shrikhande, BK | 1 |
| Altug, ME; Duran, N; Oksuz, H; Onlen, Y; Tamer, C; Yakan, S | 1 |
| Goh, BT; Rackstraw, S; Viswalingam, ND | 1 |
| Blondeau, JM; Hedlin, P | 1 |
| Amin, PD; Jain, SP; Rajadhyaksha, NS; Shah, SP; Singh P S, PP | 1 |
| Bai, XQ; Deng, SJ; Li, L; Li, R; Liang, QF; Luo, SY; Sun, XG; Wang, ZQ | 1 |
| Choi, JS; Joo, CK; Kim, KA; Lim, JA; Park, SH | 1 |
| Al-Kassas, RS; El-Khatib, MM | 1 |
| Banerjee, R; Carvalho, E; Jain, D | 1 |
| Abdelbary, G | 1 |
| Hosny, KM | 1 |
| Ohtori, A; Tojo, K; Ueda, K | 1 |
| Ari, S; Dal, T; Dayan, S; Dursun, B; Kaya, S; Kortak, MZ; Tekin, R | 1 |
| Carmichael, T; Choonara, YE; du Toit, LC; Govender, T; Kumar, P; Pillay, V | 1 |
| Garg, T; Goyal, AK; Modgill, V; Rath, G | 1 |
| Deshmukh, SR; Mahajan, HS | 1 |
| Awwad, S; Baskakova, A; Brocchini, S; Gill, H; Jiménez, JQ; Khaw, PT; Novikov, O; Williams, GR; Zhilyakova, E | 1 |
| Alam, MA; Anis, A; Hoque, M; Mohanty, B; Pal, K; Prasad, MPJG; Qureshi, D; Rawooth, M; Sarkar, P | 1 |
| Al-Joufi, FA; Alshehri, S; Ghoneim, MM; Ibrahim, MA; Muharram, MM; Salem-Bekhit, MM; Shakeel, F; Taha, EI | 1 |
| Adel Ali Youssef, A; Alzahrani, A; Bandari, S; Majumdar, S; Repka, MA; Senapati, S; Tripathi, S | 1 |
2 trial(s) available for ciprofloxacin and eye
| Article | Year |
|---|---|
Comparative tear concentrations of topically applied ciprofloxacin, ofloxacin, and norfloxacin in human eyes.
Topics: Administration, Topical; Adult; Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Eye; Female; Humans; Male; Middle Aged; Norfloxacin; Ofloxacin; Ophthalmic Solutions; Spectrophotometry, Ultraviolet; Tears | 1997 |
Antimicrobial effect of ciprofloxacin, povidone-iodine, and gentamicin in the decontamination of human donor globes.
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Colony Count, Microbial; Disinfection; Eye; Eye Banks; Eye Infections, Bacterial; Gentamicins; Humans; In Vitro Techniques; Ophthalmic Solutions; Povidone-Iodine; Tissue Donors | 1998 |
31 other study(ies) available for ciprofloxacin and eye
| Article | Year |
|---|---|
Intraocular safety of ciprofloxacin.
Topics: Animals; Anterior Chamber; Ciprofloxacin; Corneal Diseases; Eye; Lens, Crystalline; Punctures; Rabbits; Retina; Vitrectomy; Vitreous Body | 1991 |
[Intraocular penetration of ciprofloxacin after infusion and oral administration].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aqueous Humor; Ciprofloxacin; Eye; Eye Diseases; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Ophthalmologic Surgical Procedures; Surgical Wound Infection; Vitreous Body | 1988 |
Determination of robust ocular pharmacokinetic parameters in serum and vitreous humor of albino rabbits following systemic administration of ciprofloxacin from sparse data sets by using IT2S, a population pharmacokinetic modeling program.
Topics: Animals; Blood-Retinal Barrier; Chromatography, High Pressure Liquid; Ciprofloxacin; Computer Simulation; Eye; Male; Models, Biological; Rabbits; Vitreous Body | 1995 |
Toxicity and pharmacokinetics of ciprofloxacin.
Topics: Animals; Aqueous Humor; Chromatography, High Pressure Liquid; Ciprofloxacin; Electroretinography; Eye; Fundus Oculi; Injections; Rabbits; Retina; Vitreous Body | 1993 |
Intravitreal delivery of ciprofloxacin.
Topics: Animals; Anti-Infective Agents; Aqueous Humor; Ciprofloxacin; Delayed-Action Preparations; Drug Delivery Systems; Drug Implants; Endophthalmitis; Eye; In Vitro Techniques; Lactic Acid; Polyesters; Polymers; Polyvinyl Alcohol; Rabbits | 1996 |
Emerging ciprofloxacin-resistant Pseudomonas aeruginosa.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Eye; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1999 |
Comparative studies on topical lomefloxacin and ciprofloxacin on ocular kinetic and experimental corneal ulcer.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Biological Availability; Chromatography, High Pressure Liquid; Ciprofloxacin; Corneal Ulcer; Eye; Female; Fluoroquinolones; Hydrogen-Ion Concentration; Male; Quinolones; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 1999 |
Pharmacokinetics of ciprofloxacin in the human eye: a clinical study and population pharmacokinetic analysis.
Topics: Adult; Aged; Anti-Infective Agents; Ciprofloxacin; Eye; Female; Humans; Male; Middle Aged | 2000 |
Preparation of in situ-forming ophthalmic gels of ciprofloxacin hydrochloride for the treatment of bacterial conjunctivitis: in vitro and in vivo studies.
Topics: Algorithms; Animals; Anti-Infective Agents; Aqueous Humor; Chromatography, Thin Layer; Ciprofloxacin; Conjunctivitis, Bacterial; Drug Stability; Eye; Female; Gels; In Vitro Techniques; Male; Ophthalmic Solutions; Rabbits; Rheology; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet | 2003 |
[In vitro fluoroquinolone resistance in ocular bacterial isolates].
Topics: Actinomyces; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Eye; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; In Vitro Techniques; Norfloxacin; Ofloxacin | 2003 |
Multicomposite ultrathin capsules for sustained ocular delivery of ciprofloxacin hydrochloride.
Topics: Adsorption; Animals; Anti-Infective Agents, Local; Calcium Phosphates; Capsules; Ciprofloxacin; Cornea; Delayed-Action Preparations; Drug Compounding; Drug Stability; Electrolytes; Erythrocytes; Eye; Female; Goats; In Vitro Techniques; Male; Microscopy, Electron, Scanning; Ophthalmic Solutions; Osmotic Pressure; Rabbits | 2004 |
Design and evaluation of soluble ocular drug insert for controlled release of ciprofloxacin hydrochloride.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Ciprofloxacin; Delayed-Action Preparations; Drug Delivery Systems; Drug Design; Eye; Membranes, Artificial; Rabbits; Solubility | 2006 |
Comparative trial of different anti-bacterial combinations with propolis and ciprofloxacin on Pseudomonas keratitis in rabbits.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Corneal Opacity; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Ethanol; Eye; Keratitis; Propolis; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Random Allocation | 2007 |
Can chlamydial conjunctivitis result from direct ejaculation into the eye?
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cervix Uteri; Chlamydia Infections; Chlamydia trachomatis; Ciprofloxacin; Conjunctivitis, Inclusion; Doxycycline; Ejaculation; Eye; Female; Homosexuality, Male; Humans; Male; Metronidazole; Neisseria gonorrhoeae; Risk Factors; Sexual Behavior; Sexual Partners; Treatment Outcome; Urethra; Urethritis | 2006 |
Comparative minimal inhibitory and mutant prevention drug concentrations of four fluoroquinolones against ocular isolates of Haemophilus influenzae.
Topics: Anti-Infective Agents; Antimutagenic Agents; Aza Compounds; Ciprofloxacin; Dose-Response Relationship, Drug; Eye; Fluoroquinolones; Gatifloxacin; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Osmolar Concentration; Quinolines | 2007 |
In situ ophthalmic gel of ciprofloxacin hydrochloride for once a day sustained delivery.
Topics: Acrylic Resins; Animals; Anti-Infective Agents; Ciprofloxacin; Delayed-Action Preparations; Drug Administration Schedule; Drug Carriers; Drug Stability; Eye; Female; Gels; Hydrogen-Ion Concentration; Hypromellose Derivatives; Ion Exchange Resins; Methylcellulose; Phase Transition; Rabbits | 2008 |
[Analysis on susceptibility of ocular bacterial pathogens to four kinds of fluoroquinolone].
Topics: Anti-Bacterial Agents; Bacteria; Ciprofloxacin; Eye; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin | 2008 |
The resistance patterns of normal ocular bacterial flora to 4 fluoroquinolone antibiotics.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Bacteria, Aerobic; Ciprofloxacin; Conjunctiva; Eye; Fluoroquinolones; Gatifloxacin; Gram-Positive Bacteria; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines | 2009 |
Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers.
Topics: Alginates; Anti-Bacterial Agents; Anti-Infective Agents; Biological Availability; Chemistry, Pharmaceutical; Ciprofloxacin; Drug Administration Routes; Drug Carriers; Drug Delivery Systems; Escherichia coli; Eye; Gels; Methylcellulose; Ophthalmic Solutions; Polymers | 2009 |
Biodegradable hybrid polymeric membranes for ocular drug delivery.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Carboxymethylcellulose Sodium; Cell Line; Ciprofloxacin; Drug Delivery Systems; Escherichia coli; Eye; Goats; Hemolysis; Humans; Mechanical Phenomena; Membranes, Artificial; Microbial Sensitivity Tests; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Mucins; Polyvinyl Alcohol; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Toxicity Tests, Acute; Wettability | 2010 |
Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes.
Topics: Adhesiveness; Animals; Anti-Bacterial Agents; Chitosan; Ciprofloxacin; Drug Carriers; Drug Compounding; Eye; Liposomes; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Mucous Membrane; Ophthalmic Solutions; Particle Size; Rabbits; Solubility; Staphylococcus aureus; Static Electricity; Surface Properties; Toxicity Tests, Acute | 2011 |
Ciprofloxacin as ocular liposomal hydrogel.
Topics: Amines; Animals; Biological Availability; Chemistry, Pharmaceutical; Cholesterol; Ciprofloxacin; Eye; Hydrogel, Polyethylene Glycol Dimethacrylate; Liposomes; Phosphatidylcholines; Rabbits | 2010 |
Effects of pathological conditions on ocular pharmacokinetics of antimicrobial drugs.
Topics: Administration, Topical; Animals; Anti-Infective Agents; Ciprofloxacin; Cornea; Diffusion; Eye; Ofloxacin; Rabbits; Retina; Sclera; Time Factors; Vitreous Body | 2010 |
Evaluation of cutaneous palpebral anthrax.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Cefazolin; Child; Child, Preschool; Ciprofloxacin; Eye; Female; Humans; Infant; Male; Middle Aged; Penicillins; Skin Diseases, Bacterial; Sulbactam; Young Adult | 2013 |
In vitro, in vivo, and in silico evaluation of the bioresponsive behavior of an intelligent intraocular implant.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Ciprofloxacin; Computer Simulation; Drug Delivery Systems; Eye; Eye, Artificial; Indomethacin; Inflammation; Polymers; Polysaccharides; Rabbits | 2014 |
Permeability study of ciprofloxacin from ultra-thin nanofibrous film through various mucosal membranes.
Topics: Animals; Anti-Bacterial Agents; Cell Membrane Permeability; Ciprofloxacin; Delayed-Action Preparations; Diffusion Chambers, Culture; Drug Carriers; Drug Compounding; Drug Liberation; Eye; Goats; Intestinal Mucosa; Mouth Mucosa; Nanofibers; Organ Specificity; Polyvinyl Alcohol; Rectum; Skin; Trachea | 2016 |
Development and evaluation of gel-forming ocular films based on xyloglucan.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Delivery Systems; Eye; Gels; Glucans; Materials Testing; Microscopy, Electron, Scanning; Ophthalmic Solutions; Polymers; Rabbits; Xylans | 2015 |
Electrospun formulations of acyclovir, ciprofloxacin and cyanocobalamin for ocular drug delivery.
Topics: Acyclovir; Administration, Ophthalmic; Anti-Bacterial Agents; Antiviral Agents; Ciprofloxacin; Drug Compounding; Drug Delivery Systems; Drug Liberation; Eye; Polyesters; Povidone; Vitamin B 12; Vitamin B Complex | 2016 |
Synthesis and characterization of novel tamarind gum and rice bran oil-based emulgels for the ocular delivery of antibiotics.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Eye; Hydrogen Bonding; Plant Oils; Rice Bran Oil; Tamarindus | 2020 |
Enhancing Ocular Bioavailability of Ciprofloxacin Using Colloidal Lipid-Based Carrier for the Management of Post-Surgical Infection.
Topics: Animals; Anti-Bacterial Agents; Aqueous Humor; Ciprofloxacin; Disease Management; Drug Carriers; Eye; Lipids; Male; Rabbits; Staphylococcus aureus; Surgical Wound Infection | 2022 |
Formulation development and in Vitro-Ex vivo characterization of hot-melt extruded ciprofloxacin hydrochloride inserts for ocular applications: Part I.
Topics: Animals; Bacterial Infections; Ciprofloxacin; Delayed-Action Preparations; Drug Delivery Systems; Eye; Rabbits | 2023 |